BOLT · CIK 0001641281 · operating
Bolt Biotherapeutics, Inc. (BOLT) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $9 million, Bolt Biotherapeutics, Inc. is a micro-cap company. The stock currently trades at $4.64, up 2.65% today, with a 52-week range of $4.27–$9.66.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.65 | $-1.65 | +9.8% | |
| 2023 | $-1.83 | $-1.83 | +22.5% | |
| 2022 | $-2.36 | $-2.36 | — | |
| 2021 | — | — | — |